Manufacturers Life Insurance Company, The Dice Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$25.86 - $46.71 $1.04 Million - $1.87 Million	-40,087 Reduced 72.48%	15,222 $707,000
Q1 2023 May 15, 2023	BUY	$26.05 - $32.31 $153,695 - $190,629	5,900 Added 10.67%	61,209 $1.75 Million
Q4 2022 Aug 11, 2023	BUY	$19.77 - $42.23 $45,431 - $97,044	2,298 Added 4.33%	55,309 $1.73 Million
Q4 2022 Feb 13, 2023	BUY	$19.77 - $42.23 $45,431 - $97,044	2,298 Added 4.33%	55,309 $1.73 Million
Q3 2022 Aug 11, 2023	SELL	$14.97 - $22.65 $4,251 - $6,432	-284 Reduced 0.53%	53,011 $1.08 Million
Q3 2022 Nov 03, 2022	SELL	$14.97 - $22.65 $4,251 - $6,432	-284 Reduced 0.53%	53,011 $1.05 Million
Q2 2022 Aug 11, 2023	BUY	$13.19 - $22.1 $75,275 - $126,124	5,707 Added 11.99%	53,295 $827,000
Q2 2022 Aug 15, 2022	BUY	$13.19 - $22.1 $75,275 - $126,124	5,707 Added 11.99%	53,295 $817,000
Q1 2022 Aug 11, 2023	SELL	$14.54 - $25.02 $198,049 - $340,797	-13,621 Reduced 22.25%	47,588 $910,000
Q1 2022 May 20, 2022	BUY	$14.54 - $25.02 $691,929 - $1.19 Million	47,588 New	47,588 $917,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.